University of Nebraska-Lincoln

Why Zika Became More Dangerous: Discovery Offers Clues

ArticlePress release
Current Medical News
Infectious Diseases
Contributed byMaulik P. Purohit MD MPHOct 06, 2017

University of Nebraska-Lincoln virologists have identified a Zika mutation that may help explain why the virus became more lethal during outbreaks that sickened tens of thousands of people in the Caribbean, South America and the United States in 2015 and 2016.

Genomic and phylogenetic analysis previously suggested that genetic evolution transformed the mosquito-borne pathogen from one that causes fairly mild ailments to one that can result in birth defects and neurological impairment.

Experiments conducted by Asit K. Pattnaik and other scientists affiliated with the Nebraska Center for Virology showed that the mutated virus involved in the recent outbreaks contains a sugar, known as N-linked glycan, in the protein enveloping the virus. That sugar is not present in many older strains of the virus traced to Africa. The virus that caused the outbreak in the Americas is believed to have arisen in Asia.

The research team found that the mutated virus was more likely to pass from the bloodstream to the brain in infected mice and it was more likely to cause inflammation of the brain and death.

"In one virus, the outer coat has some sugars on it, and that virus goes to the brain very easily," said Pattnaik, a professor in the School of Veterinary Medicine and Biomedical Sciences. "A virus that does not have the sugar on the outer coat, does not go into the brain readily."

Early samples of the virus, isolated before the 1960s, did not have the sugars in their protein envelope, but versions that emerged after about 2007 all have those sugars, Pattnaik said.

The finding could help explain why the outbreak caused a dramatic increase in microcephaly -- abnormally small heads -- in babies of mothers who had been infected with Zika, he said. If the virus passes from the mother to her fetus, it may kill neurons in the fetal brain and prevent it from developing properly.

The findings, published Sept. 20 in the Journal of Virology published by the American Society for Microbiology, were publicly revealed almost simultaneously with those from China-based scientists who found a change of a single amino acid made the virus more dangerous to developing brain cells. That study showed a change in a pre-membrane protein could cause microcephaly; the Nebraska study showed how glycosylation of the envelope protein may contribute to the virus efficiently gaining entry into the brain.

"It should be noted that there are likely to be many factors that contributed to the development of a more pathogenic Zika virus," Pattnaik said. "These are two of those to have been recently discovered."

Pattnaik and other Nebraska scientists continue to investigate how the virus breaks the barrier between the brain and the bloodstream and to develop a drug that could be used to treat Zika infection.

Pattnaik's co-authors on the glycosylation research were Arun S. Annamalai, Aryamav Pattnaik and Bikash R. Sahoo, graduate research assistants in the School of Veterinary Medicine and Biomedical Sciences; assistant professor Satish Kumar Natarajan and post-doctoral researcher Ezhumalai Muthukrishnan from the Department of Nutrition and Health Sciences; David Steffen, a professor with the Veterinary Diagnostic Center; assistant professor Hiep Vu from the Department of Animal Science; Gustavo Delhon, director of the School of Veterinary Medicine and Biomedical Sciences; Fernando Osorio, professor with the School of Veterinary Medicine and Biomedical Sciences; Thomas M. Petro, oral biology professor at the University of Nebraska Medical Center; and Shi-hua Xiang, assistant professor with the School of Veterinary Medicine and Biomedical Sciences.


Materials provided by University of Nebraska-LincolnNote: Content may be edited for style and length.

Disclaimer: DoveMed is not responsible for the accuracy of the adapted version of news releases posted to DoveMed by contributing universities and institutions.

References:

Arun S. Annamalai, Aryamav Pattnaik, Bikash R. Sahoo, Ezhumalai Muthukrishnan, Sathish Kumar Natarajan, David Steffen, Hiep L. X. Vu, Gustavo Delhon, Fernando A. Osorio, Thomas M. Petro, Shi-hua Xiang, Asit K. Pattnaik. (2017). Zika Virus Encoding Non-Glycosylated Envelope Protein is Attenuated and Defective in NeuroinvasionJournal of Virology. DOI: 10.1128/JVI.01348-17

Was this article helpful

On the Article

Maulik P. Purohit MD MPH picture
Approved by

Maulik P. Purohit MD MPH

Assistant Medical Director, Medical Editorial Board, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!